Systematic Reviews
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jun 28, 2020; 26(24): 3495-3516
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3495
Table 5 Summary of prospective studies (overall clinical success rate, per-indication clinical success rate and adverse event rate)
Ref.
Year
Type of study
Country
Patients (n)
Overall clinical success rate (%)
Follow-up (wk)
Adverse events, n (%)
Indications
Total
FistulaBleedingPerforationLeakER3Stent fixation
Maekawa et al[21]2015ProspectiveJapan12----11/12-11/12NR0.0
Voermans et al[24]2012Prospective Multi-centerNetherlands36--32/36---32/261-260.0
Lee et al[26]2017Prospective Multi-centerKorea191/4-1/110/121/2-13/19720.0
Arezzo et al[28]2012Case series ProspectiveItaly14---12/14--12/14160.0
Schlag et al[29]2013ProspectiveGermany6--6/6---6/64-120.0
Gubler et al [31]2012Case series ProspectiveSwitzerland14--12/14---12/144-48NR
Singhal et al[32]2014Case series ProspectiveUnited States109/10-----9/1070.0
Schmidt et al[4]2015Prospective Multi-center RCTInternational124----18/24-18/2442 (8.3)
Correia et al[36]2014Case series ProspectivePortugal64/5-1/1---5/6NR0.0
Goenka et al[37]2017ProspectiveIndia122/36/63/3---11/124-80.0
Surace et al[38]2011ProspectiveItaly1914/19-----14/19321 (5.3)
Kochhar et al[39]2017Case series ProspectiveUnited States12---8/12--8/12601 (8.3)
Manta et al[40]2017ProspectiveItaly76---61/76--61/76NR0.0
Parodi et al[41]2010ProspectiveItaly104/5-3/31/2--8/10NR0.0
Sulz et al[52]2014Case series ProspectiveSwitzerland196/111/1-4/6-1/112/19NR0.0
Magdeburg et al[53]2015ProspectiveGermany43--42/43---42/43NR3 (7.0)
Keren et al[55]2014Case series ProspectiveIsrael26---21/26--21/26NR0.0
Hagel et al[57]2012Case series ProspectiveGermany17--11/17---11/174NR
Mangiafico et al[63]2017Case series ProspectiveInternational277/7-----7/72-80.0
Schmdtt et al[4]2018Prospective RCTInternational333-28/33----28/3340.0
Prosst et al[66]2015ProspectiveGermany2018/20-----18/20240.0
Mizrahi et al[67]2016ProspectiveUnited States516/173/43/412/24-1/225/5148NR
Chan et al [75]2014Case series ProspectiveChina9-7/9----7/98NR
Keen et al[76]2019ProspectiveUnited Kingdom59-55/59----55/594NR
Tashima et al[85]2017ProspectiveJapan50----47/50-47/5024 (8)
Kappelle et al[89]2018ProspectiveNetherlands13----11/13-11/13245 (38.4)
Total61770.3%89.3%89.1%75.0%87.1%66.7%81.7%-3.4%
71/101100/112114/128129/17288/1012/3504/617-16/4674